In this context, the objective of the present work was to study in a prospective way the metabolic and expression profiles of DPPIV in patients with CRC analyzing tissue from the adenoma-adenocarcinoma sequence and plasma samples, and to correlate the obtained results with classic histopathological parameters for tumor prognosis and survival. The gene discussed is DPP4; the disease is adenocarcinoma.